Probability of long-term glioblastoma survival assessed

May 28, 2012
Probability of long-Term  glioblastoma survival assessed

(HealthDay) -- Although the overall mortality rate of glioblastoma is high, compared with patients newly diagnosed with glioblastoma, those who survive two years or more after diagnosis have a favorable conditional probability of future survival, according to a study published online May 8 in Cancer.

To investigate the conditional probability of survival, Derek R. Johnson, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a population-based analysis using , , and End Results data from 10,022 patients diagnosed with glioblastoma between 1998 and 2008 who had been treated with radiation-containing regimens.

The researchers found that median survival for the cohort was 12.61 months. At diagnosis, the conditional probability of surviving an additional two years was 19.8 percent and this increased to 65.9 percent at five years after diagnosis. Compared with patients diagnosed in 1998 to 2004, an increased proportion of patients diagnosed in 2005 to 2008 survived 12 months from diagnosis and from six, 12, and 18 months after diagnosis. Age was the only factor associated with a higher risk of death at diagnosis and at one and three years following diagnosis.

"Patients surviving past two years from diagnosis have a relatively favorable conditional probability of survival into the future compared to newly diagnosed patients," the authors write. "This effect becomes more pronounced with increasing time since . These data will assist in the counseling of glioblastoma survivors."

Explore further: Glioblastoma in the 21st century: Wealthier patients living longer than poorer patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Glioblastoma in the 21st century: Wealthier patients living longer than poorer patients

June 2, 2011
Survival rates of wealthier patients and those younger than 70 with glioblastoma, the most common and aggressive malignant brain tumor, have improved since 2000, whereas rates for those living in poorer areas and older than ...

Study finds association between genetic mutation and age at diagnosis for common childhood cancer

March 13, 2012
Certain mutations of the gene ATRX were associated with age at diagnosis in children and young adults with advanced-stage neuroblastoma, a cancer that grows in parts of the nervous system, according to a study in the March ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.